Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis

Table 2 Comparisons of lipid levels in E_2/2, E_3/3, E_3/4 both gallstone patients and controls

Lipids (mmol/L)	E2/3		E3/3		E3/4
	Patients (n = 10)	Controls (n = 5)	Patients (n = 69)	Controls (n = 37)	Patients (n = 8)	Controls (n = 6)
TG	1.43 ± 0.35a	1.06 ± 0.10	0.97 ± 0.21	0.64 ± 0.44	1.11 ± 0.33	0.92 ± 0.16
TC	2.99 ± 0.65	2.52 ± 0.53	3.14 ± 0.59	3.67 ± 0.76	3.94 ± 0.45	3.62 ± 0.63
LDL-C	1.41 ± 0.56a	2.04 ± 0.16	1.87 ± 0.49	2.43 ± 0.67	1.92 ± 0.64	2.46 ± 0.32
VLDL-C	0.68 ± 0.26a	0.48 ± 0.20	0.46 ± 0.20	0.30 ± 0.11	0.42 ± 0.13	0.44 ± 0.10
HDL-C	0.95 ± 0.23	1.02 ± 0.15	0.89 ± 0.30a	1.28 ± 0.23	0.86 ± 0.21	0.90 ± 0.36
HDL2-C	0.53 ± 0.13	0.62 ± 0.22	0.49 ± 0.18b	0.73 ± 0.13	0.44 ± 0.19	0.55 ± 0.18
HDL3-C	0.42 ± 0.12	0.56 ± 0.28	0.39 ± 0.12b	0.55 ± 0.11	0.40 ± 0.13	0.46 ± 0.12

^aP < 0.05,

^bP < 0.01, vs controls; F test.